Les Sulewski
Stock Analyst at Truist Securities
(0.22)
# 4,109
Out of 4,761 analysts
11
Total ratings
20%
Success rate
-34.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Les Sulewski
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
PCRX Pacira BioSciences | Upgrades: Hold | $8 → $25 | $25.16 | -0.64% | 6 | Jan 30, 2025 | |
AMRX Amneal Pharmaceuticals | Maintains: Buy | $10 → $12 | $7.83 | +53.26% | 3 | Oct 2, 2024 | |
COLL Collegium Pharmaceutical | Maintains: Buy | $40 → $42 | $29.13 | +44.18% | 2 | Aug 9, 2024 |
Pacira BioSciences
Jan 30, 2025
Upgrades: Hold
Price Target: $8 → $25
Current: $25.16
Upside: -0.64%
Amneal Pharmaceuticals
Oct 2, 2024
Maintains: Buy
Price Target: $10 → $12
Current: $7.83
Upside: +53.26%
Collegium Pharmaceutical
Aug 9, 2024
Maintains: Buy
Price Target: $40 → $42
Current: $29.13
Upside: +44.18%